Keapstone Therapeutics Limited (10594127) is a private limited with share capital incorporated on 01/02/2017 (9 years old) and registered in sheffield, S14DP. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Keapstone therapeutics is a single asset biotech developing drugs that target the nrf2 signalling pathway (keap1 inhibitors) for two devastating conditions – parkinson’s and motor neuron disease (mnd) – which together affect more than 130,000 people in the uk. keapstone was co-founded in february 20...